September 23, 2017 AHF accuses Bristol-Myers Squibb of lying about cooperation with HIV/AIDS community Today AIDS Healthcare Base taken care of immediately a declaration placed by drug giant Bristol-Myers Squibb on its website defending it is record on AIDS medication prices and accessibility Click here . AHF, the biggest global AIDS business, accuses the business of lying about its cooperation with the HIV/Helps community and refutes the next claim made by BMS: For last 20 years, Bristol-Myers Squibb spent some time working collaboratively with the HIV/AIDS community to help meet the needs of people living with this disease, and we are focused on helping ensure that people living with AIDS and HIV have access to our medicines. The contract was reached between Gilead and the ADAP Crisis Task Drive of the National Alliance of Condition & Territorial Helps Directors . Related StoriesCancer diagnosis improvements in England: an interview with Lucy Elliss-BrookesRE. ‘Gilead’s offer of additional special discounts and cost freezes on its three major AIDS treatments, its expansion of eligibility for its patient assistance plan from 300 percent of Federal Poverty Guidelines to 500 percent and its own elimination of minimum obligations for sufferers through Gilead’s co-payment assistance system should enable many cash-strapped claims to maintain their ADAPs operating and providing treatment usage of low income individuals in need.